HER2 status was reassessed in the metastatic brain specimen to confirm concordance with the primary tumor, acknowledging known intratumoral and intertumoral heterogeneity in HER2 expression in gastric carcinoma, which has significant treatment implications. The gene discussed is ERBB2; the disease is gastric carcinoma.